Performance of the Real-Q EBV Quantification Kit for Epstein-Barr Virus DNA Quantification in Whole Blood
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
There has been increasing interest in standardized and quantitative Epstein-Barr virus (EBV) DNA testing for the management of EBV disease. We evaluated the performance of the Real-Q EBV Quantification Kit (BioSewoom, Korea) in whole blood (WB). Nucleic acid extraction and real-time PCR were performed by using the MagNA Pure 96 (Roche Diagnostics, Germany) and 7500 Fast real-time PCR system (Applied Biosystems, USA), respectively. Assay sensitivity, linearity, and conversion factor were determined by using the World Health Organization international standard diluted in EBV-negative WB. We used 81 WB clinical specimens to compare performance of the Real-Q EBV Quantification Kit and artus EBV RG PCR Kit (Qiagen, Germany). The limit of detection (LOD) and limit of quantification (LOQ) for the Real-Q kit were 453 and 750 IU/mL, respectively. The conversion factor from EBV genomic copies to IU was 0.62. The linear range of the assay was from 750 to 106 IU/mL. Viral load values measured with the Real-Q assay were on average 0.54 log10 copies/mL higher than those measured with the artus assay. The Real-Q assay offered good analytical performance for EBV DNA quantification in WB.
Abstract
There has been increasing interest in standardized and quantitative Epstein-Barr virus (EBV) DNA testing for the management of EBV disease. We evaluated the performance of the Real-Q EBV Quantification Kit (BioSewoom, Korea) in whole blood (WB). Nucleic acid extraction and real-time PCR were performed by using the MagNA Pure 96 (Roche Diagnostics, Germany) and 7500 Fast real-time PCR system (Applied Biosystems, USA), respectively. Assay sensitivity, linearity, and conversion factor were determined by using the World Health Organization international standard diluted in EBV-negative WB. We used 81 WB clinical specimens to compare performance of the Real-Q EBV Quantification Kit and artus EBV RG PCR Kit (Qiagen, Germany). The limit of detection (LOD) and limit of quantification (LOQ) for the Real-Q kit were 453 and 750 IU/mL, respectively. The conversion factor from EBV genomic copies to IU was 0.62. The linear range of the assay was from 750 to 106 IU/mL. Viral load values measured with the Real-Q assay were on average 0.54 log10 copies/mL higher than those measured with the artus assay. The Real-Q assay offered good analytical performance for EBV DNA quantification in WB.
참고문헌 (14)
- Gulley ML, "Using Epstein-Barr viral load assays to diagnose, monitor, and prevent posttransplant lymphoproliferative disorder", Clin Microbiol Rev, 23, pp.350~366 (2010)
- Heslop HE, "How I treat EBV lymphoproliferation", Blood, 114, pp.4002~4008 (2009)
- San-Juan R, "Epstein-Barr virus-related post-transplant lymphoproliferative disorder in solid organ transplant recipients", Clin Microbiol Infect, 20(S7), pp.109~118 (2014)
- Gärtner B, "EBV viral load detection in clinical virology", J Clin Virol, 48, pp.82~90 (2010)
- Hayden RT, "Factors contributing to variability of quantitative viral PCR results in proficiency testing samples: a multivariate analysis", J Clin Microbiol, 50, pp.337~345 (2012)
- Fryer JF, "Collaborative study to evaluate the proposed 1st WHO international standard for Epstein-Barr Virus (EBV) for nucleic acid amplification (NAT)-based assays", World Health Organization, ~ (2011)
- Smith TF, "Quantitative real-time polymerase chain reaction for evaluating DNAemia due to cytomegalovirus, Epstein-Barr virus, and BK virus in solid-organ transplant recipients", Clin Infect Dis, 45, pp.1056~1061 (2007)
- 하지혜, "Real-time PCR을 이용한 Epstein-Barr Virus DNA 검사 평가", Laboratory Medicine Online, 6(1), pp.31~35 (2016), 대한진단검사의학회
- CLSI, "Evaluation of detection capability for clinical laboratory measurement procedures; Approved Guideline – Second ed. CLSI document EP17-A2", Clinical and Laboratory Standards Institute, ~ (2012)
- Gullett JC, "Quantitative nucleic acid amplification methods for viral infections", Clin Chem, 61, pp.72~78 (2015)
- Semenova T, "Multicenter evaluation of whole-blood Epstein-Barr viral load standardization using the WHO international standard", J Clin Microbiol, 54, pp.1746~1750 (2016)
- Ruf S, "Comparison of six different specimen types for Epstein-Barr viral load quantification in peripheral blood of pediatric patients after heart transplantation or after allogeneic hematopoietic stem cell transplantation", J Clin Virol, 53, pp.186~194 (2012)
- Ouedraogo DE, "Comparison of EBV DNA viral load in whole blood, plasma, B-cells and B-cell culture supernatant", J Med Virol, 86, pp.851~856 (2014)
- Germi R, "Comparison of commercial extraction systems and PCR assays for quantification of Epstein-Barr virus DNA load in whole blood", J Clin Microbiol, 50, pp.1384~1389 (2012)